Attorney General Jason Miyares has announced a multistate settlement with Mylan Inc., now part of Viatris, designed to address the opioid crisis. The agreement could deliver up to $335 million nationwide. Virginia is expected to receive approximately $6.6 million as part of this settlement.
Mylan has been involved in the production and sale of various opioids since 2005, including generic fentanyl patches, oxycodone, hydrocodone, and buprenorphine. State attorneys allege that Mylan promoted these products as being less likely to be abused when, in fact, they were highly susceptible to misuse. The misleading marketing strategies allegedly encouraged overprescribing and contributed to the flow of opioids into illegal markets.
The settlement, which spans nine years, was negotiated by Virginia alongside the attorneys general of California, Illinois, Massachusetts, New York, North Carolina, Oregon, Tennessee, and Utah. Collaborative efforts also included the attorneys general from Colorado, Delaware, Georgia, Idaho, Iowa, and Vermont.